PharmaCyte Biotech, Inc. (PMCB) — Shareholders' Equity

Annual figures by fiscal year, from SEC filings.

2010: -$2.45M2011: -$2.73M2012: -$2.28M2013: -$1.50M2014: $8.94M2015: $7.78M2016: $6.52M2017: $8.09M2018: $5.77M2019: $5.04M2020: $5.09M2021: $6.68M2022: $89.92M2023: $72.69M2024: $27.65M2025: $51.89M$51.89M
2010Shareholders' Equity (USD)2025
Fiscal YearShareholders' EquityChange YoY
2025$51.89M+87.7%
2024$27.65M-62.0%
2023$72.69M-19.2%
2022$89.92M+1246.2%
2021$6.68M+31.3%
2020$5.09M+1.0%
2019$5.04M-12.6%
2018$5.77M-28.7%
2017$8.09M+24.0%
2016$6.52M-16.1%
2015$7.78M-13.0%
2014$8.94M+695.6%
2013-$1.50M+34.1%
2012-$2.28M+16.5%
2011-$2.73M-11.3%
2010-$2.45M